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Summary
Background Countries have restricted international arrivals to delay the spread of severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2). These measures carry a high economic and social cost, and might have little effect on 
COVID-19 epidemics if there are many more cases resulting from local transmission compared with imported cases. 
Our study aims to investigate the extent to which imported cases contribute to local transmission under different 
epidemic conditions.
Methods To inform decisions about international travel restrictions, we calculated the ratio of expected COVID-19 
cases from international travel (assuming no travel restrictions) to expected cases arising from internal spread, 
expressed as a proportion, on an average day in May and September, 2020, in each country. COVID-19 prevalence and 
incidence were estimated using a modelling framework that adjusts reported cases for under-ascertainment and 
asymptomatic infections. We considered different travel scenarios for May and September, 2020: an upper bound 
with estimated travel volumes at the same levels as May and September, 2019, and a lower bound with estimated 
travel volumes adjusted downwards according to expected reductions in May and September, 2020. Results were 
interpreted in the context of local epidemic growth rates.
Findings In May, 2020, imported cases are likely to have accounted for a high proportion of total incidence in many 
countries, contributing more than 10% of total incidence in 102 (95% credible interval 63–129) of 136 countries when 
assuming no reduction in travel volumes (ie, with 2019 travel volumes) and in 74 countries (33–114) when assuming 
estimated 2020 travel volumes. Imported cases in September, 2020, would have accounted for no more than 10% of 
total incidence in 106 (50–140) of 162 countries and less than 1% in 21 countries (4–71) when assuming no reductions 
in travel volumes. With estimated 2020 travel volumes, imported cases in September, 2020, accounted for no more 
than 10% of total incidence in 125 countries (65–162) and less than 1% in 44 countries (8–97). Of these 44 countries, 
22 (2–61) had epidemic growth rates far from the tipping point of exponential growth, making them the least likely to 
benefit from travel restrictions.
Interpretation Countries can expect travellers infected with SARS-CoV-2 to arrive in the absence of travel restrictions. 
Although such restrictions probably contribute to epidemic control in many countries, in others, imported cases are 
likely to contribute little to local COVID-19 epidemics. Stringent travel restrictions might have little impact on 
epidemic dynamics except in countries with low COVID-19 incidence and large numbers of arrivals from other 
countries, or where epidemics are close to tipping points for exponential growth. Countries should consider local 
COVID-19 incidence, local epidemic growth, and travel volumes before implementing such restrictions.
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Introduction
COVID-19 is an illness caused by severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2), which was first 
detected in Wuhan, China, in late 2019. Since then, it 
has been spread by travellers to almost every country in 
the world, and was declared a pandemic by WHO on 
March 22, 2020.1 In the absence of effective pharma-
ceutical measures for prevention and treatment, govern-
ments have imposed a range of response measures to 
delay the spread of SARS-CoV-2, and hence enable health 
systems to cope with the expected sharp rise in health-
care demand.
One such intervention that has been widely used is 
international travel restrictions. Early travel restrictions 
focused on countries with early outbreaks (such as 
China, Iran, and Italy), but as SARS-CoV-2 spread to more 
countries, the number of origin countries on  travel 
restriction lists has grown. The World Tourism Organi-
zation reports that every country in the world had imposed 
some form of COVID-19-related travel restriction by 
April 20, 2020, marking the most extensive travel res-
trictions in history.2 However, the restrictions implemented 
differ from country to country and include border closures, 
flight suspensions, and quarantine and self-isolation for 
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travellers. Measures can also be applied indiscriminately 
or targeted at specific places of origin.
International travel restrictions carry a high economic 
and social cost. Much of global tourism, trade, business, 
education, and labour mobility relies on cross-border 
movement of people. The UN Conference on Trade and 
Development estimates that the world’s tourism sector 
will lose value worth 1·6–2·8% of global gross domestic 
product as a result of COVID-19.3 This excludes the value 
of lost non-tourism travel, which is difficult to estimate. 
Additionally, the Organisation for Economic Co-operation 
and Development (OECD) estimates that complete 
travel res trictions could increase service trade costs 
by 12%.4 The social cost comes in the form of lost oppor-
tunities for family and friend reunion, international 
education, and career development. According to 
the 2005 International Health Regulations, travel res-
trictions “shall not be more restrictive of international 
traffic and not more invasive or intrusive to persons than 
reasonably available alter natives that would achieve the 
appropriate level of health protection”.5 Hence, there are 
strong economic, humani tarian, and legal reasons to 
impose international travel restrictions only when the 
benefits outweigh the costs.
Some studies have looked at the impact of international 
travel restrictions on the spread of COVID-19 globally. 
Most of these studies focused on the initial phase of 
the COVID-19 spread, when the epidemic was mainly 
concentrated in Wuhan, China;6–9 these studies modelled 
the effect of flight restrictions from Wuhan or mainland 
China more generally. Chinazzi and colleagues6 also 
used a dynamic metapopulation model to estimate 
the extent to which the restrictions might have delayed 
or prevented epidemics in target countries. All of these 
studies found that travel restrictions in the early part of 
the epidemic helped to delay the spread of COVID-19 but 
could not completely prevent it due to cases having left 
China before the onset of these restrictions. However, 
these studies do not address the current issue of whether 
travel restrictions are still justified at a time when there 
are outbreaks in most countries. A further study10 looked 
at retrospective travel data up to late April, 2020, to 
examine the main international pathways that led to 
spread across the world. It concluded that travel bans 
from hotspots (such as China) were insufficient to 
control global spread completely, since epidemics had 
spread to many other countries by the time travel 
restrictions were imposed.
Travel restrictions have clear benefits when there 
are zero or few cases in the destination country. For 
instance, restrictions on travellers from Wuhan, or China 
more generally, in early 2020 might have contributed to 
slowing the global spread of SARS-CoV-2.6,9 However, 
once case numbers within a country are sufficiently large 
that local outbreaks have been established and are self-
sustaining, travel restrictions become less effective. For 
instance, the ban on European travellers to the USA on 
March 12, 2020, was too late to prevent a large epidemic 
in New York already seeded mainly by European tra-
vellers.11 Countries with established epidemics attempting 
to reduce COVID-19 incidence through stringent physical 
distancing measures such as lockdowns might impose 
travel restrictions to accelerate the reduction of new cases. 
However, this would only be effective if the number of 
cases being imported from international travellers contri-
butes substantially to overall incidence. Hence, decisions 
around travel restrictions are complex; they need to take 
into account local transmission, COVID-19 prevalence in 
Research in context
Evidence before this study
Countries are at different stages of COVID-19 epidemics, and 
many have implemented policies to minimise the risk of 
importing cases via international travel. Such policies include 
border closures, flight suspensions, and quarantine and 
self-isolation on international arrivals. Searching PubMed and 
medRxiv using the search term (“covid” OR “coronavirus” OR 
“SARS-CoV-2”) AND (“travel” OR “restrictions” OR “flight” 
OR “flights” OR “border”) for articles published in any 
language from Jan 1 to July 10, 2020, returned 118 and 
84 studies, respectively, of which 39 were relevant to our 
study. These studies either concentrated in detail on the 
risk of importation to specific countries or used a single 
epidemiological or travel dataset to estimate risk. Most of 
them focused on the risk of COVID-19 introduction from China 
or other countries that had cases early in 2020. No study 
combined country-specific travel data, prevalence estimates, 
and incidence estimates to assess the global risk of importation 
relative to current local transmission within countries.
Added value of this study
Our study considers the risk of case importation across 
162 countries, in the context of local epidemic growth rates. 
Producing estimates on a global scale allows the complex 
relationship between the prevalence of COVID-19, traveller 
volume, and incidence locally to be combined, producing a 
simple, digestible metric. This allows decision makers to 
determine where travel restriction policies make large 
contributions to slowing local transmission, and where 
they have very little overall effect.
Implications of all the available evidence
In many countries, imported cases would make a relatively 
small contribution to local transmission, so travel restrictions 
would have very little effect on epidemics. Countries 
where travel restrictions would have a large effect on local 
transmission are those with strong travel links to countries 
with high COVID-19 prevalence or countries that have 
successfully managed to control their local outbreaks.
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source countries of travellers, and the volume of travel 
from those countries.
As of November, 2020, almost all countries have 
reported COVID-19 cases, but they differ in the stage of 
the pandemic they are in. Many countries in east Asia and 
Australasia are well past peak incidence, with some having 
reduced incidence to very low levels.12 Conver sely in other 
countries, incidence remains high, with some countries 
experiencing second waves of cases and a handful 
experiencing a third. Therefore, recom mendations about 
international travel restrictions cannot be applied uni-
formly, but instead need to take into account country 
circumstances.
In this Article, we provide information about the 
potential benefit of international travel restrictions when 
countries are experiencing different epidemic conditions, 
by comparing the number of cases resulting from inter-
national travel to those resulting from local transmission 
in 162 countries. In the absence of effective vaccines and 
antiviral drugs for prevention and treat ment, governments 
have imposed a range of non-pharma ceutical measures to 
reduce transmission of SARS-CoV-2 to a level that does 
not overburden the capacity of health systems.
Methods
Case under-ascertainment, incidence, and prevalence 
estimates
Our analysis combines estimates of SARS-CoV-2 
pre valence and incidence for countries in May and 
September, 2020, with detailed flight data, to produce risk 
ratings for each country (ie, the ratio of imported cases to 
total incidence, expressed as a proportion). Total incidence 
was inferred from deaths occurring in a country, so would 
include cases arising from local transmission as well 
as imported cases, since they would also presumably 
contribute to COVID-19 deaths in that country. We chose 
September as it was the month with the most up-to-date 
data available at the time of our analysis, and compared 
this scenario with May, when countries with large internal 
epidemics were also experiencing high volumes of out-
going travellers, thus representing a potential worst-case 
scenario of trans mission related to travel. Our metho-
dological framework is outlined in figure 1.
Prevalence and incidence estimates were derived by 
use of statistical modelling methods described else-
where13 and summarised here. First, the level of case 
ascer tainment in each country was estimated as the 
ratio of a delay-adjusted country-specific case–fatality 
ratio to an assumed baseline case–fatality ratio (derived 
from published estimates).14 Then, temporal variation in 
under-ascertainment was inferred using a Gaussian 
process: a non-parametric Bayesian framework, suited 
for statistically robust estimates of time-dependent 
functions. Finally, these temporal under-ascertain ment 
estimates were used to adjust the confirmed case time 
series.12 The adjusted case data represent the esti mated 
true number of symptomatic individuals in each country, 
which is typically substantially larger than the confirmed 
case number.13,15
To estimate incidence of destination countries, we first 
inferred a time-varying ascertainment rate for each 
country, following the methods of Russell and colleagues.13 
We then adjusted the confirmed case numbers from the 
European Centre for Disease Prevention and Control12 
with our ascertainment estimates, with the use of an 
estimated delay distribution from confirmation to death.16 
Once the case numbers had been adjusted for temporally 
varying under-ascertainment, we took the mean case 
incidence over the month in question for the corresponding 
scenario (May, 2020, for scenarios A and B, and 
September, 2020, for scenarios C and D).
Description Value Source
Incubation period Time from exposure to onset 
of symptoms
Gamma (μ=5·5, σ²=6·5) 
distribution; median 5·1 days 
(95% CI 4·5–5·8), with 97·5% of 
symptomatic cases developing 
symptoms within 11·5 days
Lauer et al 
(2020)18
Time to infectiousness, 
for symptomatic cases*
Time after exposure 
(and before symptom onset) 
from which pre-symptomatic 
transmission can occur
Median: 3·4 days 
(IQR 2·3–4·9; 95% CI 0·9–8·6)
Derived from 
He et al 
(2020)17
Infectious period, for 
symptomatic cases*
Time after incubation period 
during which case is able to 
infect others
Median 7·1 days 
(IQR 5·7– 8·5; 95% CI 2·5–11·6)
Derived from 
Wölfel et al 
(2020)19
Hospitalisation to death Time between being admitted 
to hospital and dying for 
severe cases
Median 13·0 days 
(95% CI 8·7–20·9)
Linton et al 
(2020)16
95% CIs are calculated using bootstrapping. *Time to infectiousness and infectious period are summed to arrive at 
prevalence estimates.
Table: Summary of the time delay distributions used in our model and their sources
Figure 1: Our methodology: the modelling procedure and our policy recommendations
A descriptive schematic of the modelling process used to arrive at the overall risk ratios is shown (A), 
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Prevalence of source countries (ie, countries where 
travellers are departing from) on each day was estimated as 
the sum of the new cases over the 10 most recent days (ie, 
assuming an infectious period of 10 days).16–19 This was 
then converted to a proportion by dividing by the country’s 
population. We restricted our analysis to countries that had 
reported at least ten confirmed COVID-19 deaths in total at 
least 10 days earlier, to estimate prevalence and incidence 
using the methods from Russell and colleagues;13 the 
estimated 95% credible intervals (CrIs) would be too 
wide to be informative otherwise. Details of the inference 
framework employed, computation of the incidence and 
prevalence estimates, and the limitations of our methods 
are shown in the appendix (pp 2–5).
As a final step, we adjusted both the prevalence and 
incidence estimates for the number of infections that 
are asymptomatic. We did so by assuming a wide plausible 
range of all infections (10–70%), reflecting the still-present 
uncertainty surrounding such estimates, with a median 
estimate of 50%. However, it is important to note that both 
the prevalence and incidence estimates are adjusted in 
precisely the same fashion and therefore the resulting risk 
ratings are unchanged when the proportion of asympto-
matic infections is varied. This implies the conclusions of 
our analysis are robust to changes in the estimates of the 
proportion of asymptomatic infections.
Our under-ascertainment estimates, described in a 
previous study,13 form the basis of our incidence and 
prevalence estimates. They are calculated in a Bayesian 
modelling framework, and as such, we report a median 
(95% CrI) over time for each country. This 95% CrI 
includes the uncertainty in the hospitalisation-to-death 
distribution. The incidence 95% CrIs include the 95% CrI 
from the under-ascertainment estimates and the assumed 
wide range of asymptomatic infections. However, un-
certainty in the other distributions used (table) is captured 
only in the prevalence estimates, as they require two 
additional calculation steps compared with the incidence 
estimates (appendix pp 3–4). Scenarios A and B used 
incidence and prevalence estimates from May, 2020, and 
scenarios C and D used incidence and prevalence estimates 
from September, 2020. We combined the sources 
of parameter uncertainty in country prevalence and 
incidence estimates in a Bayesian inference frame work. 
The model’s cumulative incidence estimates were vali-
dated against seroprevalence estimates in the original 
publication13 that develops the model employed here.
A mathematical model is required to estimate both 
prevalence and incidence, as the available case data do not 
necessarily reflect the true number of infections in many 
places.13,20 Furthermore, serological estimates are not 
available for enough countries for them to be used for a 
global analysis such as this.21
International travellers
International travel has decreased greatly since the 
COVID-19 pandemic began2 because of travel restrictions, 
but also owing to individual self-exclusion due to fear of 
infection and reduced business and tourism opportunities. 
Hence, we considered four scenarios for international 
travel in the hypothetical case of there being no travel res-
trictions: one each for the months May and September, 
both in 2019 and in 2020. Travel restrictions are defined for 
the purposes of this study as any measure that completely 
or almost completely prevents international arrivals from 
contri buting to local transmission, such as entry bans 
and com pul sory 14-day facility-based quarantines. Two 
scenarios (A and C) are upper-bound scenarios to illustrate 
the situation in which traveller volumes returned to levels 
seen in 2019 in the absence of travel restrictions; whereas 
the two remaining scenarios (B and D) are lower-bound 
scenarios using projected traveller volumes in 2020, which 
might underestimate the level of international travel in the 
absence of travel restrictions. Scenarios A and B used 
travel data from May, 2020, and scenarios C and D used 
travel data from September, 2020.
For scenario A, the number of travellers between each 
country was estimated using the number of passengers 
booked on flights with data from the Official Aviation 
Guide in May, 2019. For scenario B, we used the OpenSky 
database,22 which provides data on the number of flights 
each day between pairs of countries. We adjusted the 
number of international travellers between countries 
downwards using the ratio of the number of flights in 
the OpenSky database in May, 2019, and May, 2020. 
This gave a mean reduction of 63% (range 0–99) 
across countries. For scenario C, the number of travellers 
between each country was estimated using the number of 
passengers booked on flights with data from the Official 
Aviation Guide in September, 2019. For scenario D, we 
adjusted the number of international travellers between 
countries downwards using the ratio of the number of 
flights in the OpenSky database in September, 2019, and 
September, 2020. This gave a mean reduction of 48% 
(range 0·5–100) across countries. For scenarios B and D, 
where data were not available, we applied the mean 
reduction across pairs of countries with data.
We found large reductions in travel volumes across 
countries regardless of their level of travel restrictions in 
both May and September, 2020 (appendix pp 7–8), meaning 
scenarios B and D might be closest to the plausible range 
for travel volumes during the pandemic without travel 
restrictions.
Imported cases
The number of cases imported from a source country to 
a destination country on a particular date was estimated 
as the product of the prevalence on that date in the source 
country multiplied by the number of travellers from that 
country to the destination country on a single day in 
May, 2019 or 2020 (scenarios A and B, respectively) or 
September, 2019 or 2020 (scenarios C and D, respectively), 
where the 2020 estimates were downscaled using 
OpenSky data. The total number of imported cases on 
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that date was then estimated by summing the cases 
imported from all countries that had travellers to the 
destination country. We then calculated the ratio of the 
mean number of imported cases to mean total incidence, 
with both means averaged over the month in question.
For countries where imported cases were predicted to 
account for more than 1% of total incidence, we estimated 
the proportion of incoming travellers that needed to be 
averted to bring this proportion below 1%. We focused on 
the 1% threshold as it is a simple threshold at which the 
reduction to overall incidence due to travel restrictions 
would be arguably undetectable. We illustrate this by 
applying three thresholds (0·1%, 1%, and 10%) to the 
incidence over the course of an epidemic parameterised 
to match the key characteristics of COVID-19. Relaxing 
travel restrictions in countries where imported cases 
acount for 10% of local transmission leads to a minimal 
change in the resulting epidemic, and if imported cases 
account for less than 1% of local transmission, changes 
to incidence are virtually undetectable (pp 23–24). We 
assumed that incoming travellers would be averted in 
order of COVID-19 prevalence in their countries of origin 
(ie, averting travellers from the country with the highest 
prevalence first).
Reproduction number estimates
Even a small change in infected cases can be con-
sequential if a local epidemic is at the tipping point 
between slow exponential growth and decline. Hence, 
travel restrictions are more effective if they can prevent 
a country’s local epidemic from transi tioning from slow 
exponential decline to slow exponential growth, or if 
they can revert such a growth to a decline. To examine 
this, we used publicly available country-specific repro-
duction number (Rt) esti mates from EpiForecasts23 (the 
full list of Rt estimates can be found in the appendix 
[pp 10–16]). We then enumerate the countries that are 
close to the tipping point of their local epidemic 
(Rt between 0·95 and 1·05), even though they might 
have risk ratings below 1% (figure 1).
Sensitivity analyses
We did sensitivity analyses to examine whether our 
results would be affected by different rates of mortality 
under-ascertainment and using data from different 
timepoints of the pandemic. As the complete ness of 
COVID-19 death reporting has been questioned in 
low-income and middle-income settings, we examined 
the possibility that COVID-19 deaths might be under-
reported by 50% or 80% in low-income and middle-income 
countries, as classified by the OECD, in scenario D, which 
has the most similar travel volumes to current levels.24 We 
also tested whether the conclusions of our analysis 
change at different timepoints of the pandemic by using 
prevalence and incidence estimates from July, 2020. 
Finally, we did a sensitivity analysis on flight volumes, as 
Figure 2: Risk rating by country, in the absence of international travel restrictions, in each of the four scenarios about international travellers in May and September, 2020
(A) Travel assumed to be at the same levels as in May, 2019. (B) Travel estimated to be at the same levels as in May, 2020, by downscaling the May, 2019, levels by flight path-specific reduction factors 
calculated by using the ratio of the OpenSky datasets for May, 2019, and May, 2020. (C) Travel assumed to be at the same levels as in September, 2019. (D) Travel estimated to be at the same levels as 
in September, 2020, by downscaling the September, 2019, levels by flight path-specific reduction factors calculated using the ratio of the OpenSky datasets for September, 2019, and September, 2020. 
See appendix for the full list of results (p 22) and for the lower and upper 95% credible intervals of our results (pp 17–18).
C  Same levels as September, 2019 D  Same levels as September, 2020 (with OpenSky reduction)
A  Same levels as May, 2019 B  Same levels as May, 2020 (with OpenSky reduction)
Expected imported cases as percentage of estimated local incidence
<1% 1–10% >10% No data
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it has been estimated by the International Air Transport 
Association that aircraft occupancy has decreased by 
50·6% in 2020 compared with 2019.25 For simplicity, we 
assumed reductions of 50% and 80%. All analyses were 
done in R (version 4.0.2).
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. All authors had full access to all the data in the 
study and had final responsibility for the decision to 
submit for publication.
Results
136 countries were included for the May scenarios 
(A and B) and 162 for the September scenarios (C and D), 
as fewer countries in May, 2020, had reported at least 
ten COVID-19 deaths. Figure 2 shows the risk rating for 
each country, based on the ratio of imported cases to 
total incidence, for different scenarios about passenger 
reductions in both May, 2020, and September, 2020. 
For May, 2020, in the worst-case scenario of no change 
in travel patterns compared with May, 2019, travel 
restrictions are likely to have made a large difference to 
COVID-19 epidemics in most countries, with imported 
cases exceeding 10% of total incidence in 102 (95% CrI 
63–129) of 136 countries. Even so, this means imported 
cases would have contributed to no more than 10% of 
total incidence in 34 countries (7–73) and to less than 1% 
of total incidence in four countries (4–16; figure 2A). If 
we assume that travel volumes were reduced by the pro-
portions seen in OpenSky data for May, 2020, compared 
with May, 2019, imported cases would have contributed 
to more than 10% of total incidence in 74 countries 
(33–114) and no more than than 10% of total incidence 
in 62 countries (22–103), and to less than 1% in 
eight countries (4–39; figure 2B).
By September, 2020, travel restrictions are likely to 
have had a smaller impact on local epidemics compared 
with May, 2020. Assuming no change in travel patterns 
compared with September, 2019, we find that imported 
cases would have accounted for more than 10% of total 
incidence in 56 (95% CrI 22–112) of 162 countries and no 
more than 10% of total incidence in 106 countries 
(50–140), and to less than 1% in 21 countries (4–71; 
figure 2C). With reductions in travel volumes, imported 
cases accounted for more than 10% of total incidence in 
37 countries (8–85) and no more than 10% of total 
Figure 3: Percentage reduction in passenger numbers required for countries 
to bring proportion of total incidence due to imported cases to less than 1%
Figure shows 118 countries in scenario D where imported cases account for at 
least 1% of total incidence. Error bars represent the lower and upper 
95% credible intervals of our expected number of imported cases estimates. 
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incidence in 125 countries (65–162), and to less than 1% 
in 44 countries (8–97; figure 2D).
Of the 44 countries with risk ratings below 1% in 
September, 2020, 22 countries (6–61) had risk 
ratings below 1% but Rt estimates not close to their 
tipping point (ie, <0·95 or >1·05) in scenario D; when 
assuming September, 2019, travel volumes, the number 
was reduced to 13 countries (4–40). Equivalent numbers 
for other scenarios are presented in the appendix (p 22). 
These are the countries in which we are the most 
confident that lifting travel restrictions would have been 
very unlikely to cause outbreaks.
Individual country results are shown in the appendix 
(pp 9–16), alongside 95% lower and upper CrIs for each 
flight scenario (appendix pp 17–18). Assuming high rates 
of mortality under-ascertainment in the 143 low-income 
and middle-income countries included in our analysis 
does not change this picture sub stantially, since most of 
these countries do not contribute greatly to international 
travel volumes (appendix p 20). The conclusions are also 
largely unchanged when prevalence estimates from 
July, 2020, are used instead of May or September, 2020 
(appendix p 21).
Figure 3 shows the proportion by which international 
arrivals need to be averted to bring imported cases to 
less than 1% of total incidence in countries where it is at 
least 1% in scenario D. At this level, imported cases will 
make an almost undetectable contribution to epidemic 
size (appendix pp 23–24). Most of these countries would 
need to avert the majority of their international arrivals, 
although there are a few that might be able to bring 
imported cases to below 1% of total incidence by averting 
less than a quarter of arrivals. The relationship between 
imported cases and local outbreak size is shown in the 
appendix (p 9). Most countries cluster, given that high 
expected numbers of imported cases increase the 
probability of the seeding of outbreaks. However, several 
countries are outliers from the cluster, as they either have 
large outbreaks (the USA) or very small outbreaks with 
high numbers of expected imported cases (China).
Discussion
Using estimated COVID-19 prevalence in 162 countries 
together with international travel data between countries, 
we categorised countries according to the extent to which 
imported cases might contribute to local transmission 
under different epidemic conditions, in the absence of 
travel restrictions. In May, 2020, imported cases would 
have contributed to more than 10% of total incidence in the 
majority of countries without travel restrictions, and hence 
such restrictions appear to have been justified. However, 
by September, 2020, even without travel restrictions, 
imported cases would have exceeded 10% of total incidence 
in 56 countries when using September, 2019, travel 
volumes and in only 37 countries when using estimated 
travel volumes in September, 2020. Additionally, we found 
that some countries (13 when using 2019 travel volumes 
and 22 when using estimated 2020 travel volumes) fell into 
the most stringent category of having imported cases 
contribute less than 1% of total incidence and Rt either 
lower than 0·95 or higher than 1·05 in September, 2020. 
These are countries in which we are most confident that 
travel restrictions in September would have had little 
epidemiological benefit, as the countries either had 
low onwards transmission that was not approaching expo-
nential growth or imported cases will have been 
contributing little to existing high rates of local 
transmission.
Furthermore, in most of the countries where the 
proportion of imported cases is greater than 1%, it can be 
brought to less than 1% with selective restrictions 
imposed only on travellers from the highest-prevalence 
countries. However, a few countries would have to 
prevent entry by almost all international travellers to 
reach this threshold. These are generally countries where 
control of local epidemics has been achieved. For 
instance, in September, 2020, both New Zealand and 
China had low enough total incidence that the expected 
number of imported cases (six and 55, respectively) was 
close to the total incidence (ten and 45, respectively), 
meaning that imported cases could pose a real risk 
of triggering a second local epidemic wave (appendix 
pp 9–16).
Some countries with fairly large local epidemics in 
May, 2020—eg, Brazil and Mexico—still have a moderate 
level of risk associated with imported cases under 
the worst-case traveller volume scenario (scenario A), 
because of their strong connectedness to other high-
prevalence countries. Imported cases in these countries 
might be insufficient to drive local epidemics on their 
own, but could become important in driving epidemics 
that have already started if countries succeed in reducing 
local reproduction numbers close to 1, the level at which 
each new generation of infected cases is smaller than 
the last.
One example illustrating where more effective travel 
restrictions could have prevented outbreaks is the second 
wave of infections in Victoria, Australia. The wave began 
in June, when travellers under hotel quarantine infected 
hotel staff due to shortcomings in infection control 
procedures.26 We used our model to retroactively estimate 
the risk rating for Australia at that time, in an attempt to 
validate our model as a tool for policy makers. We 
estimated that the risk rating in June (mean daily 
contribution of imported cases to total incidence) 
was 264% (95% CrI 230–294), based on estimated mean 
daily number of imported cases of 111 (95% CrI 50–235) 
and mean daily total incidence of 42·1 cases (21·8–80·4). 
We can therefore conclude that our modelling framework 
provides evidence for the value of effective travel 
restrictions at that time.
Our estimates involve simplifying assumptions. We 
assume that international arrivals in a country have the 
same probability of being infected as any other person 
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selected at random from the source country. In practice, 
the risk of infected arrivals is likely to be lower because 
symptomatic cases are less likely to travel as they might 
be recuperating at home or in hospital. For those who do 
attempt to travel, they might be detected during exit 
screening in the source country or entry screening in the 
destination country. For those in their incubation period 
at the time of travel, they might develop symptoms 
during the course of their journey and be detected or 
self-declare illness upon arrival. We also did not consider 
the effect of outbound travellers on local transmission. 
Travel restrictions would also prevent infected travellers 
from leaving their source country, which would reduce 
the number of cases locally and hence mitigate 
the impact of infected inbound travellers. All these 
limitations result in overestimating the number of 
COVID-19 importations that would occur without travel 
restrictions. However, a limitation in the opposite 
direction is that we assume that all international travel 
occurs through flights, so our analysis might not 
accurately capture the risk of importation between 
countries that normally have a high volume of land 
traffic (such as rail and road travel between countries in 
continental Europe). Also, OpenSky flight data do not 
inform about a traveller’s final destination if a stopover 
flight is taken,22 so our travel volume estimates in 
scenarios B and D might be imprecise.
Our prevalence and incidence estimates are approxi-
mate and might overestimate incidence in countries 
with younger overall population structures and under-
estimate it in countries with older populations.13 
Furthermore, countries with very low case numbers are 
excluded from our analysis, as it is not possible to 
accurately estimate incidence and prevalence estimates 
for such countries. Similarly, estimates of time-varying 
reproduction numbers are approximate; the limitations 
of the EpiForecast estimates have been previously 
documented.23
Lastly, there are several sources of uncertainty in 
our analysis (appendix pp 3–4). However, the risk 
categorisation of countries remained broadly stable over 
sensitivity analyses around both country prevalence 
and incidence estimates (appendix pp 17–18, 21), 
international travel patterns (appendix pp 27–28), and 
assumed levels of under-ascertainment of COVID-19 
deaths (appendix p 20). Only very extreme scenarios 
(such as prevalence at the upper 95% CrI or travel 
volumes unchanged from 2019) substantially increased 
the number of countries where imported cases might 
contribute to more than 10% of local cases. Even in 
these unlikely scenarios, there are many countries 
where travel appears to make little difference to local 
COVID-19 epidemiology. Our study considered only 
international travel restrictions. However, the same 
methodology could be applied to examine the impact of 
internal travel restrictions (such as between states in 
the USA).
For the under-reporting 
estimates code see https://
github.com/thimotei/covid_
underreporting
For the OpenSky database see 
https://opensky-network.org
For the analysis code and 
GitHub repository see https://
github.com/thimotei/covid_
travel_restrictions
These results indicate that strict untargeted travel 
restrictions are probably unjustified in many countries, 
other than those that have both good international travel 
connections and very low local COVID-19 incidence. 
Governments needing to make detailed decisions about 
travel restrictions or quarantine white lists can use the 
methods presented here combined with the most current 
and accurate local data available.
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